This paper presents the excretory results with potassium bismuth tartrate and bismuth salicylate as those with bismuth metal were presented in a previous paper.1 The two products are discussed together because both are administered in oil, although the potassium bismuth tartrate is water-soluble and the bismuth salicylate is practically insoluble in both water and oil. The bismuth content of the potassium bismuth tartrate used was 56 per cent, and that of the bismuth salicylate, 60 per cent, by analysis. The methods of analysis for bismuth have been described for the entire group of products in a previous communication1 and will be omitted here. Both products were administered into the gluteal musculature in confined patients with and without syphilis. Excretory results were obtained from a total of six subjects the data being nearly or fairly complete on four subjects, that is, two receiving each product.
HANZLIK PJ, MEHRTENS HG, Marshall DC, Watson F, Spaulding J. CLINICAL EXCRETION OF BISMUTH: POTASSIUM BISMUTH TARTRATE AND BISMUTH SALICYLATE. Arch Derm Syphilol. 1930;22(4):605–614. doi:10.1001/archderm.1930.01440160003001
Dermatology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.